Phase 2 study of Arikace for the treatment of non-cystic fibrosis (CF) bronchiectasis - MPR
Links shared publicly online about this topic.
- 1,749total visits
Phase 2 study of Arikace for the treatment of non-cystic fibrosis (CF) bronchiectasis - MPR
empr.com —
Transave reported positive results from its Phase 2 trial in non-cystic fibrosis (CF) bronchiectasis patients for its lead investigational drug, Arikace (liposomal amikacin for inhalation).
View full resource at empr.com
Tags: Bronchiectasis, Drug, Phase 2 Clinical Trial, News
Most Recently Shared on September 14, 2009 at 6:22 pm By:
MPR News: Phase 2 study of Arikace for the treatment of non-cystic fibrosis (CF) bronchiectasis: Transa.. http://bit.ly/4lcuVY
Advertisement
